Figure 3From: In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursorIncorporation of PPI-1038 (100 μM; 72 hr) into the 16:0/22:6, 18:0/22:6 and 18:1/22:6 plasmalogens and DHA of PMD lymphocytes. N = 6. Mean ± SEM. P =[13C6]palmitic acid; G =[13C3]glycerol; D = [13C3]DHA. *, p < 0.01 vs. control.Back to article page